On the other hand, treatment of Apoe–/– or Ldlr–/– mice with a B cell depleting anti-CD20 antibody, which preferentially depletes B-2 cells, reduced atherosclerosis, and prevented the MI-induced acceleration of atherosclerosis (52–54). This evidence concerns the gene LDLR and atherosclerosis.